Anti-IL23α Neutralizing Antibody - 50 µg

This purified recombinant monoclonal antibody is a human anti-IL23α that selectively binds to the p19 subunit of heterodimeric IL-23, which is composed of p19 and IL-12 p40. The variable regions for this antibody are based on an FDA-approved drug Skyrizi® (risankizumab-rzaa), sold by AbbVie. This antibody has been tested for specific binding affinity to IL23α/IL12β antigen.

Supplier Catalog Number

 101453

Shipping conditions

 Dry ice

Storage Temperature

 -80°C

Supplier name

 BPS Bioscience
From
€458.00
Total €458.00

No surprise after checkout. All fees included

Your satisfaction first: door delivery with guaranteed replacement

Dedicated Scientific Support to select & use

Additional information

Host: Human
Clonality: Monoclonal